JUPITER NEUROSCIENCES, INC. Selling, General and Administrative Expense
JUPITER NEUROSCIENCES, INC. (JUNS) reported Selling, General and Administrative Expense of $2.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- JUPITER NEUROSCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.16M.
- JUPITER NEUROSCIENCES, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $1.57M.
- JUPITER NEUROSCIENCES, INC. selling, general and administrative expense for fiscal 2025 was $6.84M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $2.16M 10-Q · filed 2026-08-14 | $3.73M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.57M 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $6.84M 10-K · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |